TQ0172 |
2''-O-Rhamnosylicariside II
|
135293-13-9
|
98%
|
|
2''-O-Rhamnosylicariside II might be beneficial for improving postmenopausal osteoporosis. It shows potent antioxidant activity, with IC50 values of 11.5 ug/mL a...
|
T6S2140 |
β-Anhydroicaritin
|
38226-86-7
|
96.95%
|
|
1. β-Anhydroicaritin exhibits immunosuppressive effect on the mouse macrophages stimulated by LPS. 2. β-Anhydroicaritin phytosomes can inhibit enhanced bone turn...
|
T3808 |
Icariside I
|
56725-99-6
|
97.14%
|
|
Icariside I (Lcariside I) is isolated from Epimedium herb. It can stimulate osteogenic differentiation of BMSCs and inhibit bone resorption activity of osteoclas...
|
T2855 |
Icariin
|
489-32-7
|
98.49%
|
|
Icariin (Ieariline) is a flavonol glycoside, inhibiting PDE5 and PDE4 activities. Icariin also is a PPARα activator.
|
T3398 |
Icaritin
|
118525-40-9
|
98.50%
|
|
Icaritin (Anhydroicaritin) has hormone regulation activity and cardiovascular function improvement activity. Icaritin has anticancer activity, can induce S phase...
|
T3396 |
Baohuoside I
|
113558-15-9
|
98.85%
|
|
Baohuoside I (Icariside-II) is a component of Epimedium koreanum, exhibits anti-inflammatory activity and anti-osteoporosis activities.
|
T2S2150 |
Noricaritin
|
5240-95-9
|
98.87%
|
|
Noricaritin is a flavonoid derived from Epimedium root.
|
TN2081 |
Maohuoside A
|
128988-55-6
|
98.91%
|
|
Maohuoside A promotes osteogenesis of rat mesenchymal stem cells via BMP and MAPK signaling pathways.
|
TN1611 |
Epimedoside A
|
39012-04-9
|
98.94%
|
|
Epimedoside A has significant antioxidant activity in vitro.
|
TN3972 |
Epimedokoreanin B
|
161068-53-7
|
99.16%
|
|
Epimedokoreanin B (EKB), an isoprenylated flavonoid isolated from Korean Epimedium, exhibited anticancer activity in human non-small cell lung cancer (NSCLC) A54...
|
T5S2139 |
Epimedin A1
|
140147-77-9
|
99.18%
|
|
Epimedin A1 (Hexandraside F)(Hexandraside F) is a flavonoid extracted from Herba Epimedii which is one of commonly used Chinese medicines.
|
T3906 |
Epimedin A
|
110623-72-8
|
99.24%
|
|
Epimedin A has anti-osteoporosis activities in vivo.
|
T3397 |
Epmedin C
|
110642-44-9
|
99.3%
|
|
Epmedin C (Baohuoside-VI) was metabolized via desugarization, dehydrogenation, hydrogenation, dehydroxylation, hydroxylation, demethylation and glucuronidation p...
|
T6S2146 |
Epimedin B
|
110623-73-9
|
99.67%
|
|
1. Epimedin B (Epmedin B) has potential activity against osteoporosis by stimulating osteoblasts.
|
TQ0168 |
Sagittatoside B
|
118525-36-3
|
98%
|
|
Sagittatoside B is a natural product from Epimedium brevicornu Maxim.
|
TN2168 |
Sagittatoside C
|
118525-37-4
|
98%
|
|
Sagittatoside C is a natural product
|
TN1835 |
Epimedoside
|
106441-31-0
|
98%
|
|
Korepimedoside A is a natural product from Epimedium koreanum.
|
TN1771 |
Isoanhydroicaritin
|
28610-30-2
|
98%
|
|
Isoanhydroicaritin is a natural product from Epimedium brevicornu Maxim.
|
TN3264 |
8,3'-Diprenylapigenin
|
955135-37-2
|
98%
|
|
8,3'-Diprenylapigenin is a natural product for research related to life sciences. The catalog number is TN3264 and the CAS number is 955135-37-2.
|
TN1761 |
Ikarisoside F
|
113558-14-8
|
98%
|
|
Ikarisoside F and epimedin A can bind to AdoHcy hydrolase, inhibit the activity of AdoHcy hydrolase, thus regulating the cellular biomethylation as well as reduc...
|